Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: BONDRONAT
Active substances:
Ibandronic acid
Estonian, English, Latin
ATC code: M05BA06
Dosage form: film-coated tablet
Strength: 50mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: Bondronat is indicated in adults for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
Safety features: Yes
Marketing authorization holder: Atnahs Pharma Netherlands B.V. 
Marketing authorization number: EU/1/96/012 
Marketing authorization issued on: October 24, 2003 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1173170  BONDRONAT  film-coated tablet  50mg 84TK  Prescription           
1173181  BONDRONAT  film-coated tablet  50mg 28TK  Prescription      31.05.2007     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere